HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"

AuthorsMarco Caminati, Ernesto Crisafulli, Claudio Lunardi, Claudio Micheletto, Giuliana Festi, Matteo Maule, Alessandro Giollo, Giovanni Orsolini, Gianenrico Senna
JournalThe journal of allergy and clinical immunology. In practice (J Allergy Clin Immunol Pract) Vol. 9 Issue 7 Pg. 2943-2944 (07 2021) ISSN: 2213-2201 [Electronic] United States
PMID34246445 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • mepolizumab
Topics
  • Antibodies, Monoclonal, Humanized
  • Churg-Strauss Syndrome (diagnosis, drug therapy)
  • Granulomatosis with Polyangiitis (diagnosis, drug therapy)
  • Humans
  • Interleukin-5

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: